Back to Search
Start Over
One-Step Physical and Chemical Dual-Reinforcement with Hydrophobic Drug Delivery in Gelatin Hydrogels for Antibacterial Wound Healing.
- Source :
-
ACS omega [ACS Omega] 2024 Jul 29; Vol. 9 (32), pp. 34413-34427. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Gelatin-based bioadhesives, especially methacrylated gelatin (GelMA), have emerged as superior alternatives to sutureless wound closure. Nowadays, their mechanical improvement and therapeutic delivery, particularly for hydrophobic antibiotics, have received ever-increasing interest. Herein, a reinforced gelatin-based hydrogel with a hydrophobic drug delivery property for skin wound treatment was reported. First, photosensitive monomers of N '-(2-nitrobenzyl)- N -acryloyl glycinamide ( NB NAGA) were grafted onto GelMA via Michael addition, namely, GelMA- NB NAGA. Second, gelation of the GelMA- NB NAGA solution was accomplished in a few seconds under one step of ultraviolet (UV) light irradiation. Multiple effects were realized simultaneously, including chemical cross-linking initiated by lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), physical cross-linking of uncaged dual hydrogen bonding, and hydrophobic drug release along with o-NB group disintegration. The mechanical properties of the dual-reinforcement hydrogels were verified to be superior to those only with a chemical or physical single-cross-linked network. The hydrophobic anticancer doxorubicin (DOX) and antibiotic rifampicin (Rif) were successfully charged into the hydrogels, separately. The in vitro antimicrobial tests confirmed the antibacterial activity of the hydrogels against Gram-negative ( Escherichia coli ) and Gram-positive ( Staphylococcus aureus ) bacteria. The in vivo wound-healing assessment in mice further assured their drug release and efficacy. Therefore, this NB NAGA-modified GelMA hydrogel has potential as a material in skin wound dressing with a hydrophobic antibiotic on-demand delivery.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2024 The Authors. Published by American Chemical Society.)
Details
- Language :
- English
- ISSN :
- 2470-1343
- Volume :
- 9
- Issue :
- 32
- Database :
- MEDLINE
- Journal :
- ACS omega
- Publication Type :
- Academic Journal
- Accession number :
- 39157075
- Full Text :
- https://doi.org/10.1021/acsomega.4c01963